Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

500 public trials 86 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Completed

Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease

NCT00003913

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +46 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
View all 23 locations
View Trial Details
Completed

MS-275 in Treating Patients With Hematologic Cancer

NCT00015925

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +43 more
Locations
  • Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
View Trial Details
Completed

3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome

NCT00077558

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +42 more
Locations
  • Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
  • Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • M.D. Anderson Cancer Center at University of Texas Houston, Texas, United States
View Trial Details

Related conditions